[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$dnth](/topic/$dnth) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Weekly Reversal Scan 10/17/25: $CRDO $STX X hits w/90 SCTR Scores and $DLO $DNTH $SHG$BBVA $FRO $EXTR $ZGN $LMND $ACLS $VECO $TBPH $HROW $PNC with XX SCTR Scores @RichardMoglen Whew 😅 we got through another tape bomb 💣 week 🍻Cheers To The Weekend" [X Link](https://x.com/Richard62277378/status/1979292203819442482) [@Richard62277378](/creator/x/Richard62277378) 2025-10-17T21:03Z XXX followers, XXX engagements "Buy Verified Bybit Accounts $GBNX $VRNT $DNTH $ROST $IONQ $CAVA $AMC $AAPL $CNC $CI $HUM $MOH $TSLA $XOM $BABA $ADBE $AVBP $AVAV $ABM $SBUX $HUT $MS $AMZN $AMCR $BHP $CAMT $QBTS $HOOD $INTC $OSCR $GRYP $DAIC" [X Link](https://x.com/JonathanWi33452/status/1979213011937300537) [@JonathanWi33452](/creator/x/JonathanWi33452) 2025-10-17T15:48Z XXX followers, XXX engagements "$DNTH a clinical-stage bio announced it has entered into an exclusive #licensing agreement with Nanjing Leads Biolabs for DNTH212 (being developed in China by Leads Biolabs as LBL-047) a first and potentially best-in-class bifunctional BDCA2 and BAFF/APRIL inhibitor. DNTH212 is an investigational extended half-life bifunctional fusion protein. Now in Ph1. $XX million upfront + near-term milestone payments $X million milestone upon the initiation of a Dianthus-led Phase X study additional $XXX million in total development and regulatory approval milestones and sales-based milestones" [X Link](https://x.com/chuminhua432/status/1979080438317748723) [@chuminhua432](/creator/x/chuminhua432) 2025-10-17T07:02Z 2906 followers, 1571 engagements "$DNTH Dianthus Unveils 'Best-in-Class' Asset DNTH212 Fortifies Balance Sheet with $555M Cash" [Reddit Link](https://redd.it/1o84bnf) [@signalbloom](/creator/reddit/signalbloom) 2025-10-17T02:15Z X followers, X engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Weekly Reversal Scan 10/17/25: $CRDO $STX X hits w/90 SCTR Scores and $DLO $DNTH $SHG$BBVA $FRO $EXTR $ZGN $LMND $ACLS $VECO $TBPH $HROW $PNC with XX SCTR Scores @RichardMoglen Whew 😅 we got through another tape bomb 💣 week 🍻Cheers To The Weekend"
X Link @Richard62277378 2025-10-17T21:03Z XXX followers, XXX engagements
"Buy Verified Bybit Accounts $GBNX $VRNT $DNTH $ROST $IONQ $CAVA $AMC $AAPL $CNC $CI $HUM $MOH $TSLA $XOM $BABA $ADBE $AVBP $AVAV $ABM $SBUX $HUT $MS $AMZN $AMCR $BHP $CAMT $QBTS $HOOD $INTC $OSCR $GRYP $DAIC"
X Link @JonathanWi33452 2025-10-17T15:48Z XXX followers, XXX engagements
"$DNTH a clinical-stage bio announced it has entered into an exclusive #licensing agreement with Nanjing Leads Biolabs for DNTH212 (being developed in China by Leads Biolabs as LBL-047) a first and potentially best-in-class bifunctional BDCA2 and BAFF/APRIL inhibitor. DNTH212 is an investigational extended half-life bifunctional fusion protein. Now in Ph1. $XX million upfront + near-term milestone payments $X million milestone upon the initiation of a Dianthus-led Phase X study additional $XXX million in total development and regulatory approval milestones and sales-based milestones"
X Link @chuminhua432 2025-10-17T07:02Z 2906 followers, 1571 engagements
"$DNTH Dianthus Unveils 'Best-in-Class' Asset DNTH212 Fortifies Balance Sheet with $555M Cash"
Reddit Link @signalbloom 2025-10-17T02:15Z X followers, X engagements
/topic/$dnth/posts